跳至主要内容
临床试验/NCT01475071
NCT01475071已完成3 期

Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses.

Galderma R&D2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Galderma R&D
入组人数
100
试验地点
2
主要终点
Lesion Response

研究概览

简要总结

The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy with Aktilite™ lamp in subjects with mild actinic keratoses (intra-individual comparison).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female above 18 years;
  • Subject with clinical diagnosis of mild AK on the face or the scalp with or without clinical diagnosis of moderate AK on the target areas (TAs);

排除标准

  • Subject with clinical diagnosis of at least one severe AK on TAs
  • Subject with clinical diagnosis of other skin disease (including non-melanoma skin cancer) on the TAs;
  • Subject with pigmented AK on the TAs

研究组 & 干预措施

Metvix and daylight

Experimental

干预措施: Metvix and natural daylight PDT (Drug)

Metvix and lamp

Active Comparator

干预措施: Metvix and conventional PDT (Drug)

结局指标

主要结局

Lesion Response

时间窗: Week12

Percent of lesions treated at Baseline, in complete response at Week 12

Pain Score

时间窗: Baseline (during procedure), assessed after procedure

Subject self assessment of pain on a scale from 0 (no pain ) to 10 (extreme pain)

次要结局

未报告次要终点

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Intra-individual Comparison of Efficacy and Safety... | 临床试验